CAREDX, INC. Revenue
CAREDX, INC. (CDNA) reported Revenue of $131.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-30
- CAREDX, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $131.95M, a 52.23% increase year-over-year.
- CAREDX, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $117.70M, a 38.99% increase year-over-year.
- CAREDX, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $108.39M, a 25.19% increase year-over-year.
- CAREDX, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $100.06M, a 20.72% increase year-over-year.
- CAREDX, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $379.81M, a 13.79% increase from fiscal 2024.
- CAREDX, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $333.79M, a 19.07% increase from fiscal 2023.
- CAREDX, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $280.32M, a 12.89% decline from fiscal 2022.
- CAREDX, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $321.79M, a 8.57% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $131.95M 10-Q · filed 2026-07-30 | $249.65M 10-Q · filed 2026-07-30 | $358.03M derived: sum of 3 quarters · filed 2026-07-30 | $458.09M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $117.70M 10-Q · filed 2026-04-28 | $226.09M derived: sum of 2 quarters · filed 2026-04-28 | $326.14M derived: sum of 3 quarters · filed 2026-04-28 | $412.82M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $108.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $208.44M derived: sum of 2 quarters · filed 2026-02-25 | $295.12M derived: sum of 3 quarters · filed 2026-07-30 | $379.81M 10-K · filed 2026-02-25 |
| 2025-09-30 | $100.06M 10-Q · filed 2025-11-04 | $186.73M derived: sum of 2 quarters · filed 2026-07-30 | $271.42M 10-Q · filed 2025-11-04 | $358.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $86.68M 10-Q · filed 2026-07-30 | $171.36M 10-Q · filed 2026-07-30 | $257.94M derived: sum of 3 quarters · filed 2026-07-30 | $340.83M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $84.69M 10-Q · filed 2026-04-28 | $171.26M derived: sum of 2 quarters · filed 2026-04-28 | $254.15M derived: sum of 3 quarters · filed 2026-04-28 | $346.42M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $86.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $169.46M derived: sum of 2 quarters · filed 2026-02-25 | $261.74M derived: sum of 3 quarters · filed 2026-02-25 | $333.79M 10-K · filed 2026-02-25 |
| 2024-09-30 | $82.88M 10-Q · filed 2025-11-04 | $175.16M derived: sum of 2 quarters · filed 2025-11-04 | $247.21M 10-Q · filed 2025-11-04 | $312.77M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $92.27M 10-Q · filed 2025-08-06 | $164.32M 10-Q · filed 2025-08-06 | $229.89M derived: sum of 3 quarters · filed 2026-02-25 | $297.08M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $72.05M 10-Q · filed 2025-04-30 | $137.62M derived: sum of 2 quarters · filed 2026-02-25 | $204.81M derived: sum of 3 quarters · filed 2026-02-25 | $275.11M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $65.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $132.76M derived: sum of 2 quarters · filed 2026-02-25 | $203.06M derived: sum of 3 quarters · filed 2026-02-25 | $280.32M 10-K · filed 2026-02-25 |
| 2023-09-30 | $67.19M 10-Q · filed 2024-11-04 | $137.49M derived: sum of 2 quarters · filed 2024-11-04 | $214.75M 10-Q · filed 2024-11-04 | $297.14M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $70.30M 10-Q · filed 2024-07-31 | $147.56M 10-Q · filed 2024-07-31 | $229.95M derived: sum of 3 quarters · filed 2025-02-28 | $309.31M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $77.26M 10-Q · filed 2024-05-09 | $159.65M derived: sum of 2 quarters · filed 2025-02-28 | $239.00M derived: sum of 3 quarters · filed 2025-02-28 | $319.64M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $82.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $161.74M derived: sum of 2 quarters · filed 2025-02-28 | $242.38M derived: sum of 3 quarters · filed 2025-02-28 | $321.79M 10-K · filed 2025-02-28 |
| 2022-09-30 | $79.36M 10-Q · filed 2023-11-08 | $159.99M derived: sum of 2 quarters · filed 2023-11-08 | $239.41M 10-Q · filed 2023-11-08 | $318.63M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $80.63M 10-Q · filed 2023-08-08 | $160.05M 10-Q · filed 2023-08-08 | $239.27M derived: sum of 3 quarters · filed 2024-02-28 | $314.86M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $79.42M 10-Q · filed 2023-05-10 | $158.64M derived: sum of 2 quarters · filed 2024-02-28 | $234.22M derived: sum of 3 quarters · filed 2024-02-28 | $308.41M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $79.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $154.81M derived: sum of 2 quarters · filed 2024-02-28 | $229.00M derived: sum of 3 quarters · filed 2024-02-28 | $296.40M 10-K · filed 2024-02-28 |
| 2021-09-30 | $75.59M 10-Q · filed 2022-11-03 | $149.78M derived: sum of 2 quarters · filed 2022-11-03 | $217.18M 10-Q · filed 2022-11-03 | $275.82M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $74.19M 10-Q · filed 2022-08-04 | $141.59M 10-Q · filed 2022-08-04 | $200.23M derived: sum of 3 quarters · filed 2023-02-27 | $253.60M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $67.40M 10-Q · filed 2022-05-05 | $126.04M derived: sum of 2 quarters · filed 2023-02-27 | $179.41M derived: sum of 3 quarters · filed 2023-02-27 | $221.21M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $58.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $112.01M derived: sum of 2 quarters · filed 2023-02-27 | $153.81M derived: sum of 3 quarters · filed 2023-02-27 | $192.19M 10-K · filed 2023-02-27 |
| 2020-09-30 | $53.37M 10-Q · filed 2021-10-28 | $95.17M derived: sum of 2 quarters · filed 2021-10-28 | $133.55M 10-Q · filed 2021-10-28 | $169.37M derived: sum of 4 quarters · filed 2021-10-28 |
| 2020-06-30 | $41.80M 10-Q · filed 2021-07-29 | $80.18M 10-Q · filed 2021-07-29 | $116.00M derived: sum of 3 quarters · filed 2021-07-29 | $149.81M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $38.38M 10-Q · filed 2021-05-05 | $74.20M derived: sum of 2 quarters · filed 2021-05-05 | $108.01M derived: sum of 3 quarters · filed 2021-05-05 | $139.47M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $35.82M 10-K · filed 2020-02-28 | $69.63M derived: sum of 2 quarters · filed 2020-10-29 | $101.09M derived: sum of 3 quarters · filed 2020-10-29 | $127.07M 10-K · filed 2022-02-24 |
| 2019-09-30 | $33.81M 10-Q · filed 2020-10-29 | $65.27M derived: sum of 2 quarters · filed 2020-10-29 | $91.25M 10-Q · filed 2020-10-29 | $114.76M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $31.45M 10-Q · filed 2020-08-04 | $57.44M 10-Q · filed 2020-08-04 | $80.94M derived: sum of 3 quarters · filed 2020-08-04 | $102.13M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $25.98M 10-Q · filed 2020-04-30 | $49.49M derived: sum of 2 quarters · filed 2020-04-30 | $70.67M derived: sum of 3 quarters · filed 2020-04-30 | $88.50M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | $23.51M 10-K · filed 2020-02-28 | $44.69M derived: sum of 2 quarters · filed 2020-02-28 | $62.52M derived: sum of 3 quarters · filed 2020-02-28 | $76.57M 10-K · filed 2021-02-24 |
| 2018-09-30 | $21.18M 10-K · filed 2020-02-28 | $39.01M derived: sum of 2 quarters · filed 2020-02-28 | $53.06M 10-Q · filed 2019-10-31 | $65.56M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $17.82M 10-K · filed 2020-02-28 | $31.88M 10-Q · filed 2019-08-01 | $44.38M derived: sum of 3 quarters · filed 2020-02-28 | $56.57M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $14.05M 10-K · filed 2020-02-28 | $26.56M derived: sum of 2 quarters · filed 2020-02-28 | $38.75M derived: sum of 3 quarters · filed 2020-02-28 | $50.79M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $12.50M 10-K · filed 2019-03-06 | $24.69M derived: sum of 2 quarters · filed 2019-03-06 | $36.74M derived: sum of 3 quarters · filed 2019-03-06 | $48.32M 10-K · filed 2020-02-28 |
| 2017-09-30 | $12.19M 10-Q · filed 2018-11-08 | $24.24M derived: sum of 2 quarters · filed 2019-03-06 | $35.82M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $12.05M 10-K · filed 2019-03-06 | $23.63M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $11.58M 10-K · filed 2019-03-06 | |||
| 2016-12-31 | $40.63M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |